This site is intended for healthcare professionals
FDA Hero Banner - Multi-coloured pills and tablets
FDA Drug information

Aspirin-dipyridamole

Read time: 1 mins
Marketing start date: 29 Apr 2024
...
 

Summary of product characteristics


Effective Time

20221013

Version

5

Spl Product Data Elements

aspirin-dipyridamole aspirin-dipyridamole ASPIRIN ASPIRIN DIPYRIDAMOLE DIPYRIDAMOLE ALCOHOL AMMONIA BUTYL ALCOHOL CELLULOSE, MICROCRYSTALLINE D&C YELLOW NO. 10 FD&C RED NO. 40 FERROSOFERRIC OXIDE GELATIN HYPROMELLOSE PHTHALATE (31% PHTHALATE, 40 CST) HYPROMELLOSES ISOPROPYL ALCOHOL LACTOSE MONOHYDRATE METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:2) POLYETHYLENE GLYCOL, UNSPECIFIED POTASSIUM HYDROXIDE POVIDONE PROPYLENE GLYCOL SHELLAC SODIUM LAURYL SULFATE STARCH, CORN STEARIC ACID TALC TARTARIC ACID TITANIUM DIOXIDE TRIETHYL CITRATE WATER OPAQUE RED CAP OPAQUE WHITE BODY CAPSULE 618

Application Number

ANDA206753

Brand Name

Aspirin-dipyridamole

Generic Name

aspirin-dipyridamole

Product Ndc

70771-1172

Product Type

HUMAN PRESCRIPTION DRUG

Route

ORAL

Package Label Principal Display Panel

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL NDC 70771-1172-6 Aspirin and Extended-release Dipyridamole Capsules, 25 mg/200 mg Rx only 60 Capsules Aspirin and Extended-release Dipyridamole Capsules

Drug section

CME banner

Learning Zones

The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.

Click here to view

Disclaimer

The drug Prescribing Information (PI), including indications, contra-indications, interactions, etc, has been developed using the U.S. Food & Drug Administration (FDA) as a source (www.fda.gov).

Medthority offers the whole library of PI documents from the FDA. Medthority will not be held liable for explicit or implicit errors, or missing data.

Drugs appearing in this section are approved by the FDA. For regions outside of the United States, this content is for informational purposes only and may not be aligned with local regulatory approvals or guidance.